Purdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid by its owners, nearly two months after agreeing to a $7.4bn opioid settlement.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

Supreme Court hears case that could shield Purdue Pharma owners from opioid lawsuits The Supreme Court heard arguments in one of the most important corporate bankruptcy cases in decades.

Purdue Pharma asked a bankruptcy judge this week to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin ...

The $4.3 billion settlement also requires the family that owns Purdue Pharma to publicly disclose a plethora of documents on their role in the opioid crisis and subsequent litigation. (CN) — Attorneys ...

Purdue Pharma, manufacturer of the highly addictive pain killer oxycontin, declared bankruptcy in 2019 and entered into a multibillion dollar settlement over their sales practices with the ...

In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to grant a release and injunction that extinguishes direct claims against ...

Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin ...